Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives.
Our Initial Coin Offering is now LIVE. A total of 10,000,000 tokens are available at a per token price of $1.00. Help us bring an HIV vaccine to market. Visit https://t.co/YGgymRBnMC to participate. #HIV #ICO @IanScarffe @DavidDrakeVC @SimonCocking
Our 3rd presale is now LIVE. DER tokens are available at $0.90 per token with a total supply of 3,000,000. Visit https://t.co/YGgymRBnMC to participate. @SimonCocking @IanScarffe @DavidDrakeVC #HIV #Crypto